He Ting Li
Chief Tech/Sci/R&D Officer at Taizhou EOC Pharma Co., Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Xu Jing Su | M | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 years |
Xiao Ming Zou | M | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 14 years |
Xin Ni | M | 53 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 14 years |
Hong Yan Wang | F | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 years |
Qing Xu | M | 53 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 years |
Qiang Zhou | M | 58 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 years |
Huan Yang | M | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 years |
Jochem Peter Heizmann | M | 72 |
Tongji University
| 20 years |
Jie Liu | M | 61 |
Tongji University
| 24 years |
Cui Ping Gu | M | 44 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 7 years |
Xudong Zhao | M | - |
Tongji University
| 20 years |
Ting Fu | F | 32 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 years |
Song Zhou | M | 43 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 years |
Miao Jie Chen | F | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 7 years |
Wen Kong | M | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 6 years |
Zheng Yao | F | 40 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Xing Yue Liao | M | 42 |
Tongji University
| 9 years |
Jun Liu | M | 45 |
Tongji University
| 6 years |
Xiaotian Chen | M | 45 |
Tongji University
| 6 years |
Qi Ying Zhang | M | 46 |
Tongji University
| 7 years |
Tian Pei Wang | M | 44 |
Tongji University
| 5 years |
Ken Xu | M | 47 |
Tongji University
| 4 years |
Siying Chen | M | 39 |
Tongji University
| 4 years |
Guang Peng Liang | M | 48 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 2 years |
Xiaofeng Ma | M | 48 |
Tongji University
| 1 years |
Jing Lei Zhu | M | 44 |
Tongji University
| 4 years |
Yi Gang Xu | M | 50 |
Tongji University
| 1 years |
Shu Yang Fan | M | 40 |
Tongji University
| 4 years |
Ning Wang | M | 46 |
Tongji University
| 3 years |
Jing Yuan | M | 43 |
Tongji University
| 4 years |
Xiao Feng Shi | M | 49 |
Tongji University
| 1 years |
Li Hua Shen | M | 52 |
Tongji University
| 1 years |
Tao Song | M | 53 |
Tongji University
| 2 years |
Yu Fei Cai | M | 39 |
Tongji University
| 4 years |
Chun Chun Du | M | 39 |
Tongji University
| 4 years |
Jia Zhang | M | 43 |
Tongji University
| 4 years |
Jing Yong Chi | M | 47 |
Tongji University
| 4 years |
Xiang Sheng | M | 46 |
Tongji University
| 4 years |
Weiguo Xu | M | 72 |
Tongji University
| 3 years |
Bin Zheng | M | 54 |
Tongji University
| 4 years |
Li Min Wang | M | 49 |
Tongji University
| 4 years |
Qiang Jie | M | 46 |
Tongji University
| 2 years |
Cheng Li | M | - |
Tongji University
| 4 years |
Hai Long Yin | M | 48 |
Tongji University
| 3 years |
Jun Yi Zhang | M | 46 |
Tongji University
| 1 years |
Jun Zhao | M | 55 |
Tongji University
| 3 years |
Lei Yang | M | 46 |
Tongji University
| 4 years |
Shi Aimin | M | 57 |
Tongji University
| 2 years |
Wan Peng He | M | 50 |
Tongji University
| 1 years |
Tong Chen | M | 38 |
Tongji University
| 4 years |
Liang Wang | M | 47 |
Tongji University
| 4 years |
Fei Chen | M | 52 |
Tongji University
| 1 years |
Allan bin Zhang | M | 45 |
Tongji University
| 1 years |
E Tang | M | 49 |
Tongji University
| 1 years |
Chenjun Li | M | 41 |
Tongji University
| 4 years |
Li Chao Hao | M | 38 |
Tongji University
| 4 years |
Chen Jian Chu | M | 40 |
Tongji University
| 4 years |
Run Fei Deng | M | 50 |
Tongji University
| 1 years |
Chen Kai Ling | M | 48 |
Tongji University
| 1 years |
Xiao Chen | M | 39 |
Tongji University
| 4 years |
Jia Fang Jin | M | 46 |
Tongji University
| 2 years |
Chang Yan Ye | M | 46 |
Tongji University
| 4 years |
Ling Zhang | F | 46 |
Qufu Normal University
| 4 years |
Yi Min Wang | M | 73 |
Tongji University
| 3 years |
Ya Ru Li | M | 62 |
Tongji University
| 1 years |
Jiang Wang | M | 53 |
Tongji University
| 2 years |
Ding Xuan Huang | M | 52 |
Tongji University
| 3 years |
Geng Xiu Zheng | M | 60 |
Qufu Normal University
| 7 years |
Gui Fa Zhou | M | 61 |
Tongji University
| 3 years |
Alice Guyot | F | - |
Tongji University
| 1 years |
Le Min | M | 43 |
Tongji University
| 1 years |
Nan Wen Zhu | M | 56 |
Tongji University
| 3 years |
Guo Tan Lin | M | 56 |
Tongji University
| 2 years |
Ke Meng Zhang | M | 49 |
Tongji University
| 1 years |
Wei He | F | 49 |
Qufu Normal University
| 4 years |
Lin Yuan | F | - |
Tongji University
| 4 years |
Lu Yi Li | F | 44 |
Tongji University
| 4 years |
Bin Zhu | M | 63 |
Tongji University
| 2 years |
Jun Liu | M | 51 |
Tongji University
| 2 years |
Xin Hua Ji | M | 45 |
Tongji University
| 4 years |
Qun Tang | F | 54 |
Tongji University
| 2 years |
Di Ming Lou | M | 61 |
Tongji University
| 3 years |
Jin Pu | M | 64 |
Tongji University
| 3 years |
Kui Ding | M | 42 |
Tongji University
| 4 years |
Wen Jie Jin | M | 54 |
Tongji University
| 3 years |
Guanping Wang | M | 51 |
Tongji University
| 1 years |
Shang Wu Xu | M | 54 |
Tongji University
| 2 years |
Zhen Ping Sun | M | 55 |
Tongji University
| 2 years |
Qiang Zhu | M | - |
Tongji University
| 1 years |
Yu Feng Li | M | 46 |
Tongji University
| 4 years |
Chun Xie | M | 46 |
Tongji University
| 4 years |
Bing Tuan Wang | M | 43 |
Tongji University
| 3 years |
Jin Yan Li | M | 47 |
Tongji University
| - |
Xiao Xing Song | M | 43 |
Tongji University
| 3 years |
Wei Guo Ji | M | 49 |
Tongji University
| 2 years |
Lian Chao Liu | M | 49 |
Tongji University
| 2 years |
Yuan Yuan Zhang | F | 49 |
Tongji University
| 4 years |
Yun Cai Wang | M | 56 |
Tongji University
| 6 years |
Zhen Ming Ge | M | 85 |
Tongji University
| 9 years |
Shirong Tong | M | 54 |
Tongji University
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- He Ting Li
- Personal Network